GLIKEMIChESKIY KONTROL' U PATsIENTOV S SAKhARNYM DIABETOM TIPA 2 VO VREMYa INITsIATsII INSULINOTERAPII V REAL'NOY KLINIChESKOY PRAKTIKE ROSSIYSKOY FEDERATsII: REZUL'ATY ISSLEDOVANIYa CREDIT
- 作者: Antsiferov MB1
-
隶属关系:
- 期: 编号 17 (2009)
- 页面: 70-72
- 栏目: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278098
- ID: 278098
如何引用文章
全文:
详细
参考
- International Diabetes Federation. www.idf.org.
- Huxey R, et al. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006;332:73-78.
- Selvin E, et al. Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. Arch Intern Med 2008;168:2070-80.
- Stettler C, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J 2006;152:27-38.
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
- Gaede P, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;(358)580-91.
- Holmann RR, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
- The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86.
- Nathan DM, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53.
- ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59.
- ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
- Nathan DM, et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2006;49:1711-21.
- Nathan DM, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.
- International Diabetes Federation. Global diabetes Guidelines 2005.
- Freemantle N, et al. ADA 2009.
补充文件
